Pipeline
January 21, 2013
Sanofi has a vigorous pipeline of potential new medicines in key therapy areas of unmet patient need, with 65 projects in research & development. The majority are biological products and vaccines, with more than half being compounds from external research partnerships.
Therapies in advanced stages of clinical development or in the process of seeking marketing approval include:
Treatment of familial hypercholesterolemia in the EU
Treatment of relapsing multiple sclerosis in the EU and the U.S.
- Treatment of type 2 diabetes in the EU
Treatment of metastatic colorectal cancer in the EU
